AL
Alland Leila
Directeur Médical
OtherF
USUS·SEC (Form 4)
Browse the full record of transactions filed by Alland Leila, Directeur Médical. Director active across 2 companies, notably PMV Pharmaceuticals, Inc.. Cumulatively, 14 reports have been logged. The latest transaction was filed on 9 September 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
100 shares@ €3.29780.0005% mcap0.5% of flowCommon StockSEC:0001209191-21-055438
100 shares@ €3.29780.0005% mcap0.3% of flowCommon StockSEC:0001209191-21-055438:0
3,900 shares@ €3.29290.019% mcap19.6% of flowCommon StockSEC:0001209191-21-055140
3,900 shares@ €3.29290.019% mcap9.8% of flowCommon StockSEC:0001209191-21-055140:0
4,000 shares@ €3.32240.019% mcap20.3% of flowCommon StockSEC:0001209191-21-050670
4,000 shares@ €3.32240.019% mcap10.2% of flowCommon StockSEC:0001209191-21-050670:0
4,000 shares@ €3.30690.019% mcap20.2% of flowCommon StockSEC:0001209191-21-045989
4,000 shares@ €3.30690.019% mcap10.1% of flowCommon StockSEC:0001209191-21-045989:0
4,000 shares@ €3.19840.019% mcap19.6% of flowCommon StockSEC:0001209191-21-039035
4,000 shares@ €3.19840.019% mcap9.8% of flowCommon StockSEC:0001209191-21-039035:0
77,181 shares0Common StockSEC:0001493152-21-013114
77,181 shares0Common StockSEC:0001493152-21-013114:0
4,000 shares@ €3.23150.019% mcap19.8% of flowCommon StockSEC:0001209191-21-031300
4,000 shares@ €3.23150.019% mcap9.9% of flowCommon StockSEC:0001209191-21-031300:0
About Alland Leila
Alland Leila is the Chief Medical Officer and Board Member of PMV Pharmaceuticals, Inc. and ABEONA THERAPEUTICS INC. In these roles, she is responsible for medical strategy and product development, contributing to innovation in the biopharmaceutical sector.